[Childhood asthma: Danish guidelines for diagnosis and treatment]. 2013

Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
Dansk BørneAstma Center, Gentofte Hospital, Ledreborg Alle 34, 2820 Gentofte, Denmark.

These clinical guidelines were developed by the Danish Pediatric Asthma Center in collaboration with the Danish Paediatric Society. Key messages in the guidelines are: 1) Inhaled steroids are the most effective preventive medication and are first choice in children with persistent symptoms. 2) There is rarely indication for more than low to moderate doses of inhaled steroids as preventive medication. 3) There is insufficient evidence for preventive medication in pre-school children with intermittent asthma; a trial of leukotriene-receptor-antagonists or inhaled steroids could be done.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003718 Denmark A country in northern Europe, bordering the Baltic Sea and the North Sea. The capital is Copenhagen. Faeroe Islands,Faroe Islands
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice
D020024 Leukotriene Antagonists A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. Leukotriene Antagonist,Leukotriene Receptor Antagonist,Leukotriene Receptor Antagonists,Antagonists, Leukotriene,Receptor Antagonists, Leukotriene,Antagonist, Leukotriene,Antagonist, Leukotriene Receptor,Antagonists, Leukotriene Receptor,Receptor Antagonist, Leukotriene

Related Publications

Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
March 2008, The Journal of the Arkansas Medical Society,
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
March 2024, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia,
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
August 1993, Current problems in pediatrics,
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
January 2012, Scientifica,
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
March 2006, Pneumologie (Stuttgart, Germany),
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
April 2017, Allergology international : official journal of the Japanese Society of Allergology,
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
July 2020, Allergology international : official journal of the Japanese Society of Allergology,
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
June 2004, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
July 2011, Contact dermatitis,
Klaus Bønnelykke, and Søren Pedersen, and Sune L M Rubak, and Oluf Schiøtz, and Hans Bisgaard
August 2002, Arerugi = [Allergy],
Copied contents to your clipboard!